Please try another search
The investment objective in relation to the fund is to achieve long-term capital growth by investing at least 70% of the assets of HEALTH INNOVATION EQUITY in a portfolio of carefully-selected shares and other equity securities of companies that develop, produce or sell products, technologies, methods, procedures and/or services in the sectors of health care, pharmaceuticals, medical technology, biotechnology or biological sciences world-wide, which generate the best part of their profit through financing of these sectors, most of their shares are invested in these companies and/or most of their products and services offered are in these sectors. Further, their registered office or the major part of the business activity is in recognised countries.
Name | Title | Since | Until |
---|---|---|---|
Christophe Eggmann | - | 2010 | 2022 |
Mirjam Heeb | - | 2015 | 2019 |
Nathalie Flury | - | 2008 | 2014 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review